ElevateBio Capacity Update October 2024: Cell & Gene Therapy

Join Katie Jorgensen as she introduces ElevateBio BaseCamp and shares insights into our successful strategies for navigating the complex transition from clinical to commercial manufacturing in cell therapy. Katie will highlight the critical preparation and key workstreams essential for achieving commercial readiness, providing a detailed look at BaseCamp's comprehensive approach to scaling operations.

She will delve into how we ensure our staffing and training programs are strategically designed to meet the increased volume demands of commercial manufacturing, emphasizing the importance of building a skilled, prepared workforce. This session offers a valuable opportunity to learn about BaseCamp's innovative commercial readiness activities and our roadmap to becoming fully commercial-ready by 2025. We invite you to join us for this informative discussion and discover how BaseCamp is paving the way for success in the cell therapy industry.